{"transactions":[{"id":4616522,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-09-12T00:10:02.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":293000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":293000,"derivative":{"exercise_price":0.6488,"exercise_date":"2026-10-10","expiration_date":"2036-09-09","underlying":"Common Stock","underlying_shares":293000},"source":{"system":"sec-edgar","filing":"0001193125-26-389561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868494/000119312526389561/ownership.xml","form_type":"4"}},{"id":4616521,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-12T00:10:02.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on February 15, 2027, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 142,076 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":263073,"source":{"system":"sec-edgar","filing":"0001193125-26-389561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868494/000119312526389561/ownership.xml","form_type":"4"}},{"id":685018,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:49:28.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":2279,"price":0.7098,"value":1617.6342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes 93,076 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":214073,"source":{"system":"sec-edgar","filing":"0001193125-26-354517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526354517/ownership.xml","form_type":"4"}},{"id":685017,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:49:28.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":1871,"price":0.7098,"value":1328.0358,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 99,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":216352,"source":{"system":"sec-edgar","filing":"0001193125-26-354517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526354517/ownership.xml","form_type":"4"}},{"id":685016,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:49:28.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":1637,"price":0.7098,"value":1161.9426,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 104,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":218223,"source":{"system":"sec-edgar","filing":"0001193125-26-354517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526354517/ownership.xml","form_type":"4"}},{"id":685015,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:49:28.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":1637,"price":0.7098,"value":1161.9426,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 108,544 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2026."}],"balance_after":219860,"source":{"system":"sec-edgar","filing":"0001193125-26-354517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526354517/ownership.xml","form_type":"4"}},{"id":770993,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-19T23:09:00.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":3121,"price":0.7936,"value":2476.8256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 112,919 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":215497,"source":{"system":"sec-edgar","filing":"0001193125-26-231323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526231323/ownership.xml","form_type":"4"}},{"id":900248,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:13:30.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":1876,"price":0.6431,"value":1206.4556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 120,838 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":218618,"source":{"system":"sec-edgar","filing":"0001193125-26-055439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526055439/ownership.xml","form_type":"4"}},{"id":900247,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:13:30.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":1642,"price":0.6432,"value":1056.1344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 125,838 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":220494,"source":{"system":"sec-edgar","filing":"0001193125-26-055439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526055439/ownership.xml","form_type":"4"}},{"id":900246,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:13:30.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":1642,"price":0.6432,"value":1056.1344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 130,213 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 5,102 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2025."}],"balance_after":222136,"source":{"system":"sec-edgar","filing":"0001193125-26-055439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526055439/ownership.xml","form_type":"4"}},{"id":917212,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-05T23:02:44.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":318500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":318500,"derivative":{"exercise_price":0.915,"exercise_date":"2026-03-03","expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":318500},"source":{"system":"sec-edgar","filing":"0001193125-26-039763","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526039763/ownership.xml","form_type":"4"}},{"id":917211,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-05T23:02:44.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 134,588 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":223778,"source":{"system":"sec-edgar","filing":"0001193125-26-039763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526039763/ownership.xml","form_type":"4"}},{"id":997431,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-18T01:34:13.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":2877,"price":1.33,"value":3826.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 85,838 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":169926,"source":{"system":"sec-edgar","filing":"0001193125-25-284997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312525284997/ownership.xml","form_type":"4"}},{"id":1063453,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:59:15.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1837,"price":1.253,"value":2301.761,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 93,757 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":172803,"source":{"system":"sec-edgar","filing":"0001868494-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000186849425000006/ownership.xml","form_type":"4"}},{"id":1063452,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:59:15.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1608,"price":1.253,"value":2014.824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 98,757 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":174640,"source":{"system":"sec-edgar","filing":"0001868494-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000186849425000006/ownership.xml","form_type":"4"}},{"id":1063451,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:59:15.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1608,"price":1.253,"value":2014.824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 103,132 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2025."}],"balance_after":176248,"source":{"system":"sec-edgar","filing":"0001868494-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000186849425000006/ownership.xml","form_type":"4"}},{"id":1144604,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-05-16T23:07:25.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":2937,"price":0.4427,"value":1300.2099,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 107,507 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":171856,"source":{"system":"sec-edgar","filing":"0000950170-25-073824","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025073824/ownership.xml","form_type":"4"}},{"id":1214360,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:43:12.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":1598,"price":0.5384,"value":860.3632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 115,426 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":174793,"source":{"system":"sec-edgar","filing":"0000950170-25-036772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025036772/ownership.xml","form_type":"4"}},{"id":1214359,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:43:12.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":4073,"price":0.5384,"value":2192.9032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 119,801 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":176391,"source":{"system":"sec-edgar","filing":"0000950170-25-036772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025036772/ownership.xml","form_type":"4"}},{"id":1214358,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:43:12.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":1727,"price":0.5384,"value":929.8168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 131,051 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 3,409 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2024."}],"balance_after":180464,"source":{"system":"sec-edgar","filing":"0000950170-25-036772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025036772/ownership.xml","form_type":"4"}},{"id":1292682,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":215000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"1/48th of the shares underying the option vested on March 23, 2024, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":215000,"derivative":{"exercise_price":1.21,"exercise_date":"2024-03-23","expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292681,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":215000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"1/48th of the shares underying the option vested on March 23, 2024, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.22,"exercise_date":"2024-03-23","expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292680,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":205000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/48th of the shares underying the option vested on March 15, 2023, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":205000,"derivative":{"exercise_price":1.21,"exercise_date":"2023-03-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":205000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292679,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":205000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/48th of the shares underying the option vested on March 15, 2023, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.06,"exercise_date":"2023-03-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":205000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292678,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":141000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"1/48th of the shares underying the option vested on March 15, 2022, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":141000,"derivative":{"exercise_price":1.21,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":141000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292677,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":141000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"1/48th of the shares underying the option vested on March 15, 2022, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":15.19,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":141000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292676,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":69982,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/48th of the shares underying the option vested on July 17, 2021, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":69982,"derivative":{"exercise_price":1.21,"exercise_date":"2021-07-17","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":69982},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292675,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":69982,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/48th of the shares underying the option vested on July 17, 2021, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":9.36,"exercise_date":"2021-07-17","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":69982},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292674,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":235000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":235000,"derivative":{"exercise_price":1.21,"exercise_date":"2025-02-24","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":235000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292673,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":31676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F4","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the total number of shares subject to the restricted stock unit award on May 15, 2025, and 1/4th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 135,426 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":178782,"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292672,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2025, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 103,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":147106,"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1430810,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-08-17T00:26:29.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":1625,"price":2.8945,"value":4703.5625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $2.79 to $3.02. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 63,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2024."}],"balance_after":107106,"source":{"system":"sec-edgar","filing":"0000950170-24-098235","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017024098235/ownership.xml","form_type":"4"}},{"id":1430809,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-08-17T00:26:29.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":5803,"price":2.8945,"value":16796.7835,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $2.79 to $3.02. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 63,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2024."}],"balance_after":108731,"source":{"system":"sec-edgar","filing":"0000950170-24-098235","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017024098235/ownership.xml","form_type":"4"}},{"id":1614362,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-28T00:30:20.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":215000,"derivative":{"exercise_price":5.22,"exercise_date":"2024-03-23","expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0000950170-24-021548","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017024021548/ownership.xml","form_type":"4"}},{"id":1614361,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-28T00:30:20.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2024, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 83,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":108534,"source":{"system":"sec-edgar","filing":"0000950170-24-021548","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017024021548/ownership.xml","form_type":"4"}},{"id":1637378,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-17T01:35:42.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":6500,"price":5.86,"value":38090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $5.61 to $6.15. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 48,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 3,597 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2023."}],"balance_after":73534,"source":{"system":"sec-edgar","filing":"0000950170-24-016669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017024016669/ownership.xml","form_type":"4"}},{"id":1801435,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-18T22:33:02.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":5563,"price":3.81,"value":21195.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.76 to $3.87. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 64,375 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 2,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2023."}],"balance_after":76437,"source":{"system":"sec-edgar","filing":"0001209191-23-046641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000120919123046641/doc4.xml","form_type":"4"}},{"id":2006247,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-02-17T23:47:48.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":205000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":205000,"derivative":{"exercise_price":3.06,"exercise_date":"2023-03-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":205000},"source":{"system":"sec-edgar","filing":"0001209191-23-010884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000120919123010884/doc4.xml","form_type":"4"}},{"id":2006246,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-17T23:47:48.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F4","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the total number of shares subject to the restricted stock unit award on each of August 15, 2023, February 15, 2024, August 15, 2024 and February 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 80,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001209191-23-010884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000120919123010884/doc4.xml","form_type":"4"}},{"id":2006245,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-17T23:47:48.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on the six month anniversary of the Transaction Date, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 35,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-23-010884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000120919123010884/doc4.xml","form_type":"4"}},{"id":2387212,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-02-17T22:38:28.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":141000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one (1) month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":141000,"derivative":{"exercise_price":15.19,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":141000},"source":{"system":"sec-edgar","filing":"0001209191-22-010917","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000120919122010917/doc4.xml","form_type":"4"}}]}